Sign In
Buy BBH
$185.77
+4.04 (+2.22%)
At Close: Jun 03, 2026
Another Round of Coronavirus Cases Puts This Biotech ETF in Focus
04:45pm, Monday, 29'th Jun 2020
Already one of the ETFs at the center of the coronavirus investment thesis, the ALPS Medical Breakthroughs ETF (SBIO) could be poised for more upside
The Reopening Killed The V-Shaped Recovery
07:43am, Monday, 29'th Jun 2020
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19
08:51pm, Sunday, 28'th Jun 2020
GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue reading...
A Healthcare ETF Could Benefit From Index Reshuffling | ETF Trends
05:16pm, Tuesday, 23'rd Jun 2020
On Friday, FTSE Russell, one of the largest providers of benchmarks used by providers of index funds and ETFs
Biogen and Moderna shares show how biotech ETFs may look similar but act differently
07:14pm, Thursday, 18'th Jun 2020
Big shares of a losing biotech stock didn’t stop a pair of four-star-rated ETFs from moving higher Thursday. They may sound similar, but hold distinct...
Biotech ETFs: Appraising The Pipelines
12:00am, Wednesday, 17'th Jun 2020
Parsing the performance and holdings of different biotech funds.
3 Gilead-Heavy ETFs To Watch Amid The AstraZeneca-Gilead Rumor
12:00am, Monday, 08'th Jun 2020
In the race to develop a coronavirus vaccine, AstraZeneca (NYSE: AZN) and Gilead Sciences (NASDAQ: GILD) are two of the leading contenders and that could be the starting point of...
These ETF Areas Make Great Investment Choices in June
08:55pm, Tuesday, 02'nd Jun 2020
Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.
Biotech ETFs to watch as companies push for coronavirus treatments
07:42pm, Monday, 18'th May 2020
Yahoo Finance's Seana Smith and ETF Trends CIO and Director Dave Nadig discuss the outlook on biotech ETFs as optimism grows over results for coronavirus treatments.
CAPROCK Group Inc. Buys New Shares in VanEck Vectors Biotech ETF (NASDAQ:BBH)
10:32am, Friday, 01'st May 2020
CAPROCK Group Inc. bought a new stake in VanEck Vectors Biotech ETF (NASDAQ:BBH) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The i
Biotech ETFs Gain on New Positive Data for Gilead's Remdesivir
08:50pm, Thursday, 30'th Apr 2020
As the coronavirus continues to spread, the latest positive data on remdesivir is some relief in such challenging times.
Healthcare ETFs to Gain on Progress in Coronavirus Vaccine
07:29pm, Wednesday, 29'th Apr 2020
The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.
